SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-053387
Filing Date
2023-05-01
Accepted
2023-05-01 06:13:37
Documents
16
Period of Report
2023-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2314221d1_8k.htm   iXBRL 8-K 61310
2 EXHIBIT 2.1 tm2314221d1_ex2-1.htm EX-2.1 63387
3 EXHIBIT 10.1 tm2314221d1_ex10-1.htm EX-10.1 31883
4 EXHIBIT 10.2 tm2314221d1_ex10-2.htm EX-10.2 32109
  Complete submission text file 0001104659-23-053387.txt   464112

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA pmgm-20230427.xsd EX-101.SCH 4070
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pmgm-20230427_def.xml EX-101.DEF 27972
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmgm-20230427_lab.xml EX-101.LAB 39560
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmgm-20230427_pre.xml EX-101.PRE 26590
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2314221d1_8k_htm.xml XML 7155
Mailing Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301
Business Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301 (407) 808-1335
Priveterra Acquisition Corp. (Filer) CIK: 0001837607 (see all company filings)

IRS No.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40021 | Film No.: 23869780
SIC: 2834 Pharmaceutical Preparations